Erectile Rating During the Treatment of Rectal Cancers Localized

Study Overview
=================
Brief Summary
-----------------
Erectile dysfunction will be explored by recording R / P and self-administered questionnaire IIEF-5.

Detailed Description
-----------------
Erectile dysfunction will be explored by recording R / P and self-administered questionnaire IIEF-5. This dual evaluation will be made before the beginning of the therapeutic treatment and 3 months and 12 months after surgery. Assessed by IIEF-5 will be made only 6, 18 and 24 months after surgery. There will be no changes made to support oncology patients.

Official Title
-----------------
Erectile Rating During the Treatment of Rectal Cancers Localized. Exploratory Study

Conditions
-----------------
Rectal Cancer Stage I

Intervention / Treatment
-----------------
* Other: Evaluation of erectile dysfunction


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Male patient. Age greater than 18 years. Neoplastic rectal stage ≤ T3. Patient sexually active before diagnosis. Laparoscopic surgery. Medico-surgical institute Bergonié. Patient information and consent for participation in the study. Exclusion Criteria: Patients already treated for erectile dysfunction. Absence of sexual activity before diagnosis. Presence of secondary lesions at diagnosis (M +). Classified T4 tumor preoperatively. Surgery by laparotomy. History of pelvic cancer surgery prostate or bladder. History of pelvic radiotherapy (outside of the current process). History of prostate or bladder neoplasia known. Other neoplastic known. Patient for psychological, social, family or geographical could not be treated or monitored regularly according to the criteria of the study, patient deprived of liberty or under guardianship.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
Male

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Diagnostic
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Other: Register R<br>Evaluation of erectile dysfunction in the management of localized rectal cancer | Other: Evaluation of erectile dysfunction<br>* Register R / P and self-administered questionnaire IIEF-5<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| assess erectile dysfunction | Evaluate objectively the presence of erectile dysfunction induced by medico-surgical treatment of rectal cancer three months after surgery. These objective data will be obtained using the Rigiscan ® PLUS system coupled to a polysomnogram. the investigators use the abbreviation Register R / P (Rigiscan ® PLUS / polysomonographie) in this protocol. | 1 day | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Evaluate objectively the presence of erectile dysfunction before and 12 months after the medico-surgical treatment of rectal cancer | Describe objectively and qualitatively erectile dysfunction before and 3 and 12 months after the medico-surgical management. | 1 day | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Localized rectal cancer in a male patient